The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
about
A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide.Formaldehyde as a potential human leukemogen: an assessment of biological plausibility.
P2860
The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The clinical impact of tenipos ...... s with small-cell lung cancer.
@ast
The clinical impact of tenipos ...... s with small-cell lung cancer.
@en
type
label
The clinical impact of tenipos ...... s with small-cell lung cancer.
@ast
The clinical impact of tenipos ...... s with small-cell lung cancer.
@en
prefLabel
The clinical impact of tenipos ...... s with small-cell lung cancer.
@ast
The clinical impact of tenipos ...... s with small-cell lung cancer.
@en
P2093
P1476
The clinical impact of tenipos ...... ts with small-cell lung cancer
@en
P2093
P304
P356
10.1097/00000421-199710000-00008
P577
1997-10-01T00:00:00Z